Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Deferred Taxes (2016 - 2025)

Conmed (CNMD) has disclosed Deferred Taxes for 16 consecutive years, with $812000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Deferred Taxes fell 87.65% year-over-year to $812000.0, compared with a TTM value of $3.5 million through Dec 2025, down 71.13%, and an annual FY2025 reading of $3.5 million, down 71.13% over the prior year.
  • Deferred Taxes was $812000.0 for Q4 2025 at Conmed, down from $3.7 million in the prior quarter.
  • Across five years, Deferred Taxes topped out at $70.2 million in Q2 2022 and bottomed at -$44.5 million in Q4 2022.
  • Average Deferred Taxes over 5 years is $669400.0, with a median of $859500.0 recorded in 2021.
  • Peak annual rise in Deferred Taxes hit 7642.56% in 2022, while the deepest fall reached 6900.0% in 2022.
  • Year by year, Deferred Taxes stood at $4.3 million in 2021, then plummeted by 1130.68% to -$44.5 million in 2022, then surged by 103.58% to $1.6 million in 2023, then skyrocketed by 313.32% to $6.6 million in 2024, then plummeted by 87.65% to $812000.0 in 2025.
  • Business Quant data shows Deferred Taxes for CNMD at $812000.0 in Q4 2025, $3.7 million in Q3 2025, and $1.7 million in Q2 2025.